https://geovax.com/2026-07-25T22:01:46-04:00https://geovax.com/privacy-policy/2026-08-18T10:22:48-04:00https://geovax.com/about-geovax/2026-08-13T11:36:25-04:00https://geovax.com/about-geovax/leadership/2026-07-24T02:51:52-04:00https://geovax.com/about-geovax/board-of-directors-corporate-advisors/2026-07-24T04:02:37-04:00https://geovax.com/about-geovax/scientific-advisory-board/2026-08-07T15:39:05-04:00https://geovax.com/technology/2026-07-24T04:16:54-04:00https://geovax.com/technology/mva-technology-overview/2026-07-24T04:19:16-04:00https://geovax.com/technology/gedeptin-technology-overview/2026-07-24T04:20:44-04:00https://geovax.com/technology/publications/2026-07-24T04:24:09-04:00https://geovax.com/technology-pipeline/2026-08-13T11:44:46-04:00https://geovax.com/technology-pipeline/pipeline-summary/2026-07-24T04:36:56-04:00https://geovax.com/technology-pipeline/oncology/2026-07-24T04:38:58-04:00https://geovax.com/technology-pipeline/infectious-diseases/2026-07-24T04:41:23-04:00https://geovax.com/investors/2026-08-07T15:42:58-04:00https://geovax.com/investors/corporate-profile/2026-07-24T04:53:35-04:00https://geovax.com/investors/press-releases/2026-07-24T08:40:35-04:00https://geovax.com/investors/media/2026-08-07T18:11:08-04:00https://geovax.com/investors/events-presentations/2026-08-17T16:10:52-04:00https://geovax.com/investors/sec-filings/2026-07-24T20:10:33-04:00https://geovax.com/investors/stock-information/2026-07-24T17:33:36-04:00https://geovax.com/investors/corporate-governance/2026-07-29T18:32:10-04:00https://geovax.com/investors/analyst-coverage/2026-07-24T17:39:01-04:00https://geovax.com/investors/investor-faqs/2026-07-25T21:36:57-04:00https://geovax.com/careers/2026-07-24T19:18:28-04:00https://geovax.com/contact-us/2026-07-25T19:03:23-04:00https://geovax.com/about-geovax/company/2026-07-24T19:20:48-04:00https://geovax.com/geovax-news/2026-07-25T11:06:56-04:00https://geovax.com/hemorrhagic-fever-vaccine/2026-07-25T11:14:02-04:00https://geovax.com/stock-details/2026-07-25T11:16:59-04:00